Rutgers Global Health Institute director Richard Marlink is among the “experts, pundits, and social media users” interviewed for a national story about U.S. Congress members being among the first to receive coronavirus vaccines.
coronavirus
Getting Back to Work and School Safely During COVID-19: ITI Students Help Launch HLTH I.D
School of Communication and Information students developed an app intended to detect COVID-19. Institute director Richard Marlink was the student team’s industry mentor in the Rutgers I-Corps program.
Applying Science Where It’s Needed Most
Research scientist Maria Laura Gennaro deploys her immunology and microbiology expertise, honed through decades of studying tuberculosis, in the world’s fight against COVID-19.
The Impact of COVID-19 on Underserved Communities
Rutgers Global Health Institute director Richard Marlink discusses the disproportionate hardships facing low-income and minority communities in New Jersey because of the COVID-19 pandemic and why helping everyone recover is important for our state.
COVID’s Disparate Impact Panel
Rutgers Law School student organizations hosted an online event, COVID’s Disparate Impact Panel. The program featured a discussion about the disparate impact of COVID-19 on minority communities and potential solutions for moving forward.
Rutgers Awarded $5 Million NIH Grant to Improve Access to COVID-19 Testing
The New Jersey Alliance for Clinical and Translational Science at Rutgers received a $5 million NIH grant to launch outreach campaigns and expand access to COVID-19 testing for underserved and vulnerable communities in New Jersey.
Where Are We Now?
It’s been seven months since COVID-19 was declared a global pandemic. Rutgers students and faculty discuss the new normal.
Rutgers Experts Explore Questions, Concerns Over COVID-19 Vaccine Trials
As researchers race to develop a COVID-19 vaccine, two Rutgers Global Health Institute core faculty members discuss how clinical trials work, the ethics of developing and distributing a vaccine, safety and efficacy in clinical trials, and what a successful vaccine may mean.
More Than Words: Communicating About a COVID-19 Vaccine
Health officials can’t rely on a one-size-fits-all message when it comes to communicating with the public about a forthcoming COVID-19 vaccine, says Professor William Hallman, an experimental psychologist who uses scientific research to explore human behavior.
CNN Interview: Public Health Dean Perry Halkitis
Human behavior is undermining efforts to curtail the spread of COVID-19, says School of Public Health dean and epidemiologist Perry N. Halkitis in a televised interview on CNN’s Erin Burnett OutFront nightly news program.